January 24, 2025- Lumos Diagnostics is pleased to announce that it has partnered with MedPro, who will provide national contract sales coverage across health system, government and physician office markets in the USA for Lumos’ point of care test, FebriDx, a rapid point-of-care test that aids in differentiating between bacterial and non-bacterial infections. MedPro will serve as an extension to the Lumos salesforce and provide over 60 territory reps strategically positioned across the country to increase FebriDx awareness and adoption.
Under this partnership, MedPro will provide customer lead generation, sales revenue, and customer training for FebriDx. The collaboration is expected to make an immediate impact on Lumos’ US footprint, enabling increased awareness of the Company’s innovative FebriDx technology among healthcare providers. MedPro’s reach into acute care encompasses both the USA hospital environment and the federal government including DoD, VA, IHS and BOP hospitals, where the team builds relationships with decision makers and drives successful product conversions for enhanced patient care. In the non-acute care setting, MedPro services Physician Offices, Ambulatory Surgery Centers, Skilled Nursing Facilities, and Home
Health Agencies.
For more information visit lumosdiagnostics.com & www.mproassociates.com.